EPO provides notice of intent to issue European Patent Application for Aethlon Hemopu

[News]

Aethlon Medical, Inc., the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, announced today that the European Patent Office (EPO) has provided the Company a notice of intent to issue European Patent Application No. 04 703 672.8 entitled "Method For Removal of Viruses From Blood By Lectin Affinity Hemodialysis."

More... (http://www.news-medical.net/news/20121107/EPO-provides-notice-of-intent-to-issue-European-Patent-Application-for-Aethlon-Hemopurifier.aspx)